"Breakthroughs" in medicine
As Betsy has so nicely described, the history of radioimmunotherapy (RIT) is long in its development. Yet, RIT is considered "new", a "breakthrough" in the treatment of lymphoma.
It is perseverance by physicians, strengthened by the vocal, yet respectful, demand of patients, that is the key to recognition of breakthrough therapies.
This is exactly why Betsy and I continually recommend that lymphoma patients obtain consultations with physicians who are experienced in RIT.
Mort